Can a drug eruption cause an elevated C-reactive protein (CRP) level?

Can Drug Eruptions Cause Elevated CRP?

Yes, drug eruptions can cause elevated C-reactive protein (CRP) levels, though this is relatively uncommon compared to other causes of elevated CRP.

Evidence from Drug Reactions

Drug reactions are documented as a cause of markedly elevated CRP, though they represent a minority of cases. In a large retrospective study examining CRP levels above 100 mg/L, drug reactions accounted for only 1.7% of cases 1. This suggests that while drug eruptions can elevate CRP, they are not a frequent cause of significant CRP elevation.

More specifically, the 2022 drug allergy practice parameter demonstrates that certain drug-induced reactions, particularly cytokine release syndrome from biologics like rituximab, can cause substantial CRP elevation 2. The guideline explicitly lists increased CRP as a potential laboratory change in cytokine release reactions, alongside elevated ESR, LDH, creatinine, and uric acid 2.

Mechanism and Clinical Context

The mechanism differs based on the type of drug reaction:

• Cytokine release reactions (as seen with monoclonal antibodies) trigger innate immune responses involving monocytes, macrophages, T cells, and NK cells, leading to inflammatory marker elevation including CRP 2

• Mast cell-mediated hypersensitivity reactions typically show elevated tryptase rather than CRP 2

• Immune checkpoint inhibitor-related adverse events can cause CRP elevation in 93% of cases, with mean levels reaching 52.7 mg/L from baseline of 8.4 mg/L 3. Importantly, CRP elevation preceded clinical symptoms in 42% of these cases 3

Differential Diagnosis Considerations

When evaluating elevated CRP in the context of a drug eruption, you must systematically exclude more common causes:

Infection remains the predominant cause of markedly elevated CRP (55.1% of cases with CRP >100 mg/L), and the proportion increases with higher CRP levels—88.9% of cases with CRP >350 mg/L were infectious 1. Check procalcitonin to help differentiate: in drug-induced immune reactions, PCT typically remains normal (92% of cases) despite CRP elevation 3.

Other competing diagnoses include:

• Rheumatologic diseases (7.5% of markedly elevated CRP) 1
• Malignancy (5.1%) 1
• Multiple concurrent causes (5.6%) 1

Clinical Pitfalls

A common error is assuming all CRP elevations in patients on medications represent infection. The evidence shows that drug reactions, particularly immune-related adverse events from biologics and checkpoint inhibitors, can independently elevate CRP without infection 2, 3.

Another pitfall is dismissing drug eruptions as a cause when CRP is only mildly elevated. While severe elevations (>100 mg/L) are less commonly drug-related, moderate elevations are well-documented with immune-mediated drug reactions 3.

Practical Approach

When encountering elevated CRP with a drug eruption:

1. Check procalcitonin to assess for bacterial infection (should be normal in pure drug reactions)
2. Assess vital signs including temperature and hemodynamic stability
3. Review the specific drug involved—biologics and checkpoint inhibitors have higher likelihood of CRP elevation
4. Examine the pattern: CRP from cytokine release typically shows concurrent elevation of other inflammatory markers (ESR, LDH) 2
5. Consider timing: In immune checkpoint inhibitor reactions, CRP may rise before clinical symptoms appear 3

The magnitude of CRP elevation alone cannot definitively distinguish drug reactions from infection, making clinical context and additional markers essential for accurate diagnosis.